Skip to Main content Skip to Navigation
Journal articles

Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain

Cyril Goudet 1, * Eric Chapuy 2 Abdelkrim Alloui 2 Francine Acher 3 Jean-Philippe Pin 1 Alain Eschalier 2, *
* Corresponding author
2 Pharmacologie fondamentale et clinique de la douleur
INSERM - Institut National de la Santé et de la Recherche Médicale : U766, UdA - Université d'Auvergne - Clermont-Ferrand I, Neuro-Dol - Neuro-Dol
Abstract : Glutamate plays a key role in modulation of nociceptive processing. This excitatory amino acid exerts its action through two distinct types of receptors, ionotropic and metabotropic glutamate receptors (mGluRs). Eight mGluRs have been identified and divided in three groups based on their sequence similarity, pharmacology and G-protein coupling. While the role of group I and II mGluRs is now well established, little is known about the part played by group III mGluRs in pain. In this work, we studied comparatively the involvement of spinal group III mGluR in modulation of acute, inflammatory and neuropathic pain. While intrathecal injection of ACPT-I, a selective group III mGluR agonist, failed to induce any change in vocalization thresholds of healthy animals submitted to mechanical or thermal stimuli, it dose-dependently inhibited the nociceptive behavior of rats submitted to the formalin test and the mechanical hyperalgesia associated with different animal models of inflammatory (carrageenan-treated and monoarthritic rats) or neuropathic pain (mononeuropathic and vincristine-treated rats). Similar effects were also observed following intrathecal injection of PHCCC, a positive allosteric modulator of mGlu4. Antihyperalgesia induced by ACPT-I was blocked either by LY341495, a nonselective antagonist of mGluR, by MAP4, a selective group III antagonist. This study provide new evidences supporting the role of spinal group III mGluRs in the modulation of pain perception in different pathological pain states of various etiologies but not in normal conditions. It more particularly highlights the specific involvement of mGlu4 in this process and may be a useful therapeutic approach to chronic pain treatment.
Complete list of metadata

Cited literature [24 references]  Display  Hide  Download
Contributor : Cyril Goudet <>
Submitted on : Friday, September 5, 2008 - 3:34:33 PM
Last modification on : Tuesday, February 23, 2021 - 1:30:07 PM
Long-term archiving on: : Thursday, June 3, 2010 - 7:20:48 PM


Files produced by the author(s)



Cyril Goudet, Eric Chapuy, Abdelkrim Alloui, Francine Acher, Jean-Philippe Pin, et al.. Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain. PAIN, Elsevier, 2007, 137 (1), pp.112-124. ⟨10.1016/j.pain.2007.08.020⟩. ⟨inserm-00318859⟩



Record views


Files downloads